161 studies found for:    Open Studies | "Vomiting"
Show Display Options
Rank Status Study
21 Recruiting A Single Dose of Intravenous (IV) Acetaminophen Verses Placebo in the Pre-operative Setting and Outcomes on Post-operative Pain, Nausea and Vomiting
Conditions: Post Operative Pain;   Post Operative Nausea and Vomiting
Interventions: Drug: IV acetaminophen;   Drug: placebo
22 Recruiting Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Ondissolve;   Radiation: Palliative Radiation Therapy
23 Unknown  Risk Factors for Shoulder Pain and Emesis After Laparoscopic Cholecystectomy
Conditions: Shoulder Pain;   Nausea;   Vomiting
Intervention:
24 Recruiting Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan
Conditions: Dehydration;   Gastroenteritis;   Vomiting;   Diarrhea
Interventions: Drug: Ondansetron;   Drug: Placebo
25 Recruiting Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
Conditions: Nausea;   Vomiting;   Metastatic Liver Cancer
Interventions: Device: acupoint electric stimulation;   Drug: tropisetron
26 Recruiting Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan
Conditions: Dehydration;   Gastroenteritis;   Vomiting;   Diarrhea
Interventions: Drug: Ondansetron;   Drug: Placebo
27 Recruiting Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Conditions: Breast Cancer;   Nausea;   Vomiting
Interventions: Drug: granisetron transdermal system;   Drug: fosaprepitant dimeglumine;   Other: laboratory biomarker analysis
28 Unknown  Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting
Conditions: Nausea;   Vomiting
Interventions: Drug: Aprepitant, Palonosetron, Dexamethasone;   Drug: Placebo, Palonosetron, Dexamethasone
29 Recruiting Acupuncture and Nausea/Vomiting in Pediatric Patients
Condition: Postoperative Vomiting and Nausea
Intervention: Device: Acupuncture Needle
30 Unknown  Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Carbamazepine
31 Recruiting Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines
Conditions: Vomiting Syndrome;   Migraines
Intervention:
32 Recruiting Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting
Conditions: Nausea;   Vomiting
Interventions: Drug: Trimebutine Maleate (NEWBUTIN SR 300 mg Tab);   Drug: Metoclopramide hydrochloride monohydrate
33 Recruiting Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Conditions: Hematopoietic/Lymphoid Cancer;   Nausea and Vomiting;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Olanzapine;   Drug: Chemotherapy (cisplatin or cyclophosphamide and doxorubicin);   Drug: Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant);   Other: Placebo
34 Recruiting Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Palonosetron, ondansetron, dexamethasone
35 Recruiting Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections
Condition: Postoperative Nausea and Vomiting
Interventions: Drug: Dexamethasone;   Drug: Placebo
36 Recruiting Fosaprepitant for Nausea and Vomiting During High-dose Interleukin-2 (HD IL-2) for Metastatic Melanoma and Renal Cell Carcinoma
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Fosaprepitant
37 Recruiting Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031 AM4)
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant dimeglumine;   Drug: Fosaprepitant Placebo;   Drug: Dexamethasone;   Drug: Ondansetron;   Drug: Dexamethasone Placebo;   Drug: Ondansetron Placebo;   Drug: Rescue Therapy
38 Recruiting Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children Under 18 Years of Age (MK-0517-029)
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant 150 mg;   Drug: Fosaprepitant 60 mg;   Drug: Fosaprepitant 20 mg;   Drug: Placebo Fosaprepitant;   Drug: Ondansetron
39 Recruiting Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)
Condition: Radiotherapy-induced Nausea and Vomiting (RINV)
Interventions: Drug: SyB D-0701;   Drug: Placebo
40 Recruiting Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
Condition: Emesis
Interventions: Drug: Dexamethasone, Ondansetron, Aprepitant;   Other: Arm A: Standard Anti-emetic regimen

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years